Mesoblast

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Bollinger Bands

Score

0.8

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 25 14.2 0.28% 0.39% 12.8% -3.5% 25.7%
SHORT 26 16.3 0.38% 0.63% 10.2% -3.4% 47.3%

Summary

Technical Analysis


The purpose of the Bollinger Bands is to provide a relative definition of high and low. By definition prices are high at the upper band and low at the lower band. This definition can aid in rigorous pattern recognition and is useful in comparing price action of the action of indicators to arrive at systematic trading decision.

Calculation: Bollinger Bands:
1) Middle Band = 20-day simple moving average (SMA);
2) Upper Band = 20-day SMA + (20-day standard deviation of price x 2);
3) Lower Band = 20-day SMA - (20-day standard deviation of price x 2);


PROFILE: Mesoblast (MSB.AX)


Stock Exchange: ASX
Company: Mesoblast
Ticker Codes: | MSB.AX | ASX:MSB |

About Mesoblast (ASX:MSB):

Mesoblast Limited develops cell-based medicines. The company has leveraged its proprietary technology platform based on mesenchymal lineage adult stem cells to establish a portfolio of late-stage product candidates. Its allogeneic cell product candidates target advanced stages of diseases with high and unmet medical needs, including cardiovascular conditions, immunologic and inflammatory conditions, orthopedic disorders, and oncology and hematology conditions. The company's products under the Phase III clinical trials include MPC-150-IM for chronic and end-stage heart failure; MPC-06-ID for chronic low back pain; and MSC-100-IV for acute graft versus host disease in children. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, and diabetic kidney diseases and type 2 diabetes. The company has a collaboration agreement with JCR Pharmaceuticals Co., Ltd. It has operations in the United States, Australia, Singapore, and Switzerland. Mesoblast Limited was founded in 2004 and is headquartered in Melbourne, Australia.

Top 10:

Bollinger Bands

Download
Company Close Change(%) Volume Value Signal
EDE Eden Energy 0.05 70.4 29,966,662 17.88 BULLISH
TBR Tribune Resources 5.6 7.7 37,233 33.33 BULLISH
NMT Neometals 0.22 4.9 479,038 18.82 BULLISH
WAF West African Resources 0.33 4.8 3,311,755 62.16 BULLISH
AGG Anglogold Ashanti 5.23 4.2 13,809 29.44 BULLISH
SMX Sms Management & Technology 0.39 4.1 37,404 84.63 BULLISH
SHM Shriro 0.59 3.5 63,231 60.14 BULLISH
SXY Senex Energy 0.33 3.2 2,352,743 19.67 BULLISH
VAH Virgin Australia Holdings 0.17 3 676,369 21.8 BULLISH
MGC Mg Unit Trust 0.36 2.9 354,294 25.75 BULLISH